Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

US Patent 12297432 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
RNA-editing oligonucleotides and uses thereof2025
RNA-editing oligonucleotides and uses thereof2024
RNA-editing oligonucleotides and uses thereof2024
SERPINA1 iRNA compositions and methods of use thereof2024
RNA-editing oligonucleotides and uses thereof2024
Complement component C5 iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2024
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2023
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2023